Here are five observations:
1. Entrepreneurs should consider they are entering a sensitive industry heavily reliant on trust. Both consumers and providers practice caution when trying out new technology in healthcare.
2. To capture investors, digital health startups must demonstrate they know the market exceptionally well and prove their technology will be effective. Investors rely on a level of trust to go forward with a startup.
3. Stakeholders want to see FDA approval or certifications for startups’ products as it increases credibility and therefore, trust.
4. Clinical trials also boost credibility, demonstrating the products’ efficacy.
5. Establishing trust will take time, and digital health startups shouldn’t cut corners. Once trust is lost, due to inaccurate metrics for example, the startup won’t last long.
Recent articles:
5 legislative changes impacting ASCs — March 22, 2016
Surgery Partners proposes $400M senior notes offering, Medical Facilities Corp. revenue hits $90M in Q4 — 6 key notes on ASC companies
AmSurg employees volunteer at food bank: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.